Skip to the main content
The Crier

PHE - Corporate - Fetomaternal Alloimmune Thrombocytopenia

Your saved contracts

What the buyer wrote

Antenatal screening for fetomaternal alloimmune thrombocytopenia (FMAIT) evidence map

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Solutions for Public Health£7.9kends (31 Dec 2020)

Details

What the buyer calls it
PHE - Corporate - Fetomaternal Alloimmune Thrombocytopenia
How they are buying
Called off an existing agreementThe work went to a supplier already on a framework or dynamic market.
Type
services
Suitable for small firms
The buyer says yes. What that is worth
Work starts
26 Apr 2020
Work ends
31 Dec 2020

Who the buyer named

Sandeep Kapoor was the named contact on this notice.

sandeep.kapoor@phe.gov.uk